GBIO’s main business areas are Biological Products Development and Consulting Services.
Biological Products Development
Bionovels and Biosimilars
Development & Approval of Biological Products
●Focusing on in-house development of biological products (bionovels and biosimilars) while using CMOs for the manufacturing of products
●Collaborating with overseas partners for the multi-national clinical trials
●Preparing plans for the overall development processes from CMC/non-clinical to clinical and to MA approval (e.g. Korea MFDS(ex–FDA), the U.S. FDA, EU EMA, etc.)
●Arranging technology transfer/licensing of biological products between domestic companies/institutions or between domestic and overseas companies/institutions